Balloon Dilation of the Upper Tract
Non-drug-coated balloon dilation is a well-established minimally invasive endourologic technique for managing benign upper urinary tract strictures — including ureteral strictures, ureteropelvic junction (UPJ) obstruction, and ureteroenteric anastomotic strictures. Pooled data show technical success ~89% with moderate long-term patency ~54% at 6–12 months. The procedure is best suited to short strictures (≤2 cm) of recent onset (≤3 months) with intact vascular supply.[1][2]
For drug-coated (paclitaxel) balloons, see Drug-Coated Balloon Therapy. For sharp endoscopic incision, see Endoureterotomy.
Indications
| Scenario | Notes |
|---|---|
| Benign ureteral strictures | Iatrogenic injury, ureteroscopy, radiation, or inflammatory.[1][3] |
| UPJ obstruction | Primary or recurrent after failed pyeloplasty.[4][5] |
| Ureteroenteric anastomotic strictures | After radical cystectomy with ileal conduit, neobladder, or continent pouch.[6][7] |
| Post-surgical anastomotic strictures | After pyeloplasty, ureteral reimplantation, or ureteroneocystostomy.[8][3] |
Technique
Performed via either a retrograde (cystoscopic / ureteroscopic) or antegrade (percutaneous nephrostomy) approach under fluoroscopic guidance.[6][3]
| Parameter | Typical setting |
|---|---|
| Balloon type | Semicompliant or high-pressure; profiles 5–7 mm in pediatric cases, larger in adults.[9] |
| Inflation pressure | 10–20 atm, sustained for 5–15 min.[6] |
| Post-dilation drainage | Double-J ureteral stent or nephrostomy for 4–8 weeks on average; some protocols extend to several months.[3][6] |
| Standardization | No consensus on optimal balloon type, pressure, number of inflations, or stent retention time.[1] |
Efficacy by Scenario
| Clinical scenario | Short-term (3–6 mo) | Long-term (≥12 mo) |
|---|---|---|
| Benign ureteral strictures (pooled meta) | 60% | 54%[1] |
| Short strictures (≤2 cm), intact vascularity | 89% | —[2] |
| Long strictures (>2 cm) | 37.5% | —[2] |
| Primary UPJ obstruction | 86–95% (3 mo) | 71–76% (24 mo)[3][4][5] |
| Recurrent UPJ after pyeloplasty | 73% (3 mo) | 53% (12 mo)[6] |
| Ureteroenteric strictures | 61% (6 mo) | 16–27% (12–60 mo)[7][8][9] |
| Acute strictures (≤3 mo onset) | 88% | —[3] |
Predictors of Outcome
- Stricture length ≤2 cm.
- Early intervention (≤3 months from onset).
- Intact vascular supply (no prior radiation, no devascularizing dissection).
- Primary rather than recurrent stricture.
- Multiple strictures (independent predictor on multivariate analysis).
- Compromised vascular supply (post-radiation, ischemic).
- Long strictures.
- Prior failed repair.
- Smaller balloon circumference.
Comparison With Surgical Reconstruction
| Parameter | Balloon Dilation | Laparoscopic / Robotic Pyeloplasty |
|---|---|---|
| Operative time | ~67 min | 150–178 min[13] |
| Blood loss | Minimal | Greater |
| Length of stay | ~3 d | 5–7 d |
| Cost | Lower | Higher |
| Long-term patency | Inferior | Significantly better at 12 and 24 mo[13][4] |
For ureteroenteric strictures, open surgical revision achieves 69% patency at 60 months versus only 27% for endourologic approaches.[7]
Adjunctive Techniques
- Balloon dilation + endoureterotomy — higher success than dilation alone (87% vs 78% at 1 yr for lower-ureteral strictures).[11]
- Laser incision + triamcinolone injection followed by balloon dilation — 83% long-term success for ureteroenteric strictures.[14]
- Acucise balloon catheter (combined electrocautery incision + dilation) — 75% success for post-reimplantation strictures.[15]
Clinical Role
Balloon dilation is best positioned as a first-line minimally invasive option for selected patients — short, acute, primary strictures with intact vascularity — and as a temporizing or alternative approach in patients unfit for open reconstruction. Re-dilation is feasible for recurrence; most recurrences develop within the first 12 months, mandating long-term surveillance.[7][16]
See Also
- Endoureterotomy
- Drug-Coated Balloon Therapy
- Pyeloplasty
- Ureteroenteric Anastomotic Stricture Repair
- Upper Tract Reconstruction Principles
References
1. Lu C, Zhang W, Peng Y, et al. Endoscopic balloon dilatation in the treatment of benign ureteral strictures: a meta-analysis and systematic review. J Endourol. 2019;33(4):255–262. doi:10.1089/end.2018.0797
2. Richter F, Irwin RJ, Watson RA, Lang EK. Endourologic management of benign ureteral strictures with and without compromised vascular supply. Urology. 2000;55(5):652–657. doi:10.1016/s0090-4295(00)00484-2
3. Beckmann CF, Roth RA, Bihrle W. Dilation of benign ureteral strictures. Radiology. 1989;172(2):437–441. doi:10.1148/radiology.172.2.2748824
4. Xu N, Chen SH, Xue XY, et al. Comparison of retrograde balloon dilatation and laparoscopic pyeloplasty for treatment of ureteropelvic junction obstruction: results of a 2-year follow-up. PLoS One. 2016;11(3):e0152463. doi:10.1371/journal.pone.0152463
5. Wei C, Wang T, Chen S, Ren X, Chen X. Concomitant management of renal calculi and recurrent ureteropelvic junction obstruction with percutaneous nephrolithotomy and antegrade balloon dilation. J Int Med Res. 2020;48(5):300060520911252. doi:10.1177/0300060520911252
6. Ravery V, de la Taille A, Hoffmann P, et al. Balloon catheter dilatation in the treatment of ureteral and ureteroenteric stricture. J Endourol. 1998;12(4):335–340. doi:10.1089/end.1998.12.335
7. van Son MJ, Lock MTWT, Peters M, van de Putte EEF, Meijer RP. Treating benign ureteroenteric strictures: 27-year experience comparing endourological techniques with open surgical approach. World J Urol. 2019;37(6):1217–1223. doi:10.1007/s00345-018-2475-4
8. Anastasescu R, Merrot T, Chaumoître K, Panuel M, Alessandrini P. Antegrade percutaneous balloon dilation of ureteral strictures after failed pelviureteric or ureterovesical reimplantation in children. Urology. 2011;77(6):1444–1449. doi:10.1016/j.urology.2010.10.052
9. Parente A, Angulo JM, Romero RM, et al. Management of ureteropelvic junction obstruction with high-pressure balloon dilatation: long-term outcome in 50 children under 18 months of age. Urology. 2013;82(5):1138–1143. doi:10.1016/j.urology.2013.04.072
10. Lewis-Russell JM, Natale S, Hammonds JC, Wells IP, Dickinson AJ. Ten years' experience of retrograde balloon dilatation of pelvi-ureteric junction obstruction. BJU Int. 2004;93(3):360–363. doi:10.1111/j.1464-410x.2003.04617.x
11. Wang B, Gao W, Yang K, et al. Analysis of the efficacy and risk factors for failure of balloon dilation for benign ureteral stricture. J Clin Med. 2023;12(4):1655. doi:10.3390/jcm12041655
12. Shapiro MJ, Banner MP, Amendola MA, et al. Balloon catheter dilation of ureteroenteric strictures: long-term results. Radiology. 1988;168(2):385–387. doi:10.1148/radiology.168.2.3393656
13. Zi D, Cao W, Chen F, Zhu L. Management for benign ureteral stricture: comparison of robot-assisted laparoscopy, conventional laparoscopy, and balloon dilation. J Endourol. 2023;37(8):868–875. doi:10.1089/end.2023.0047
14. Katims AB, Edelblute BT, Tam AW, et al. Long-term outcomes of laser incision and triamcinolone injection for the management of ureteroenteric anastomotic strictures. J Endourol. 2021;35(1):21–24. doi:10.1089/end.2020.0593
15. Touiti D, Gelet A, Deligne E, et al. Treatment of uretero-intestinal and ureterovesical strictures by Acucise balloon catheter. Eur Urol. 2002;42(1):49–54; discussion 55. doi:10.1016/s0302-2838(02)00070-2
16. Reus C, Brehmer M. Minimally invasive management of ureteral strictures: a 5-year retrospective study. World J Urol. 2019;37(8):1733–1738. doi:10.1007/s00345-018-2539-5